Associated Papers
Inhibitory Response to CK II Inhibitor Silmitasertib and CDKs Inhibitor Dinaciclib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines.
Ma Y et al.
International Journal of Molecular Sciences, 2022
35457227 (PubMed )
Supplement: ijms-23-04409-s001.zip › Supplementary_Tables.pdf
Select a paper to view details